CPT® Code 90698

1. Indications

The DTaP-IPV/Hib vaccine, represented by CPT® Code 90698, is indicated for the prevention of several serious infectious diseases. The specific indications for administering this vaccine include:

• Diphtheria - A bacterial infection that affects the mucous membranes of the throat and nose, leading to severe respiratory issues and potential complications.
• Tetanus - A serious bacterial infection characterized by muscle stiffness and spasms, often caused by bacteria entering the body through wounds.
• Acellular Pertussis - Also known as whooping cough, this highly contagious respiratory disease can cause severe coughing fits and complications, particularly in infants and young children.
• Haemophilus influenzae type b (Hib) - A bacterium that can cause severe infections, including meningitis and pneumonia, particularly in young children.
• Inactivated Poliovirus - A vaccine component that protects against poliomyelitis, a viral disease that can lead to paralysis and other serious complications.

2. Procedure

The administration of the DTaP-IPV/Hib vaccine involves several key procedural steps to ensure safety and efficacy:

• Step 1: Preparation - Prior to administration, the healthcare provider must gather all necessary supplies, including the vaccine vial, sterile syringes, and alcohol swabs. The vaccine should be inspected for any discoloration or particulate matter, ensuring it is safe for use.
• Step 2: Patient Assessment - The healthcare provider should assess the patient’s medical history, including any previous allergic reactions to vaccines, current health status, and any contraindications to vaccination. This step is crucial for ensuring the patient's safety during the immunization process.
• Step 3: Site Selection and Preparation - The provider will select an appropriate intramuscular injection site, typically the deltoid muscle in the upper arm for older children and adults, or the anterolateral thigh for infants. The selected site is then cleaned with an alcohol swab to reduce the risk of infection.
• Step 4: Administration of the Vaccine - The vaccine is drawn into a sterile syringe, and the provider will administer the injection at a 90-degree angle to ensure proper delivery into the muscle. Care is taken to inject the vaccine quickly and smoothly to minimize discomfort.
• Step 5: Post-Administration Care - After the injection, the provider will apply gentle pressure to the injection site with a cotton ball or gauze. The patient is monitored for a brief period to observe for any immediate adverse reactions, and the provider will provide information on potential side effects and aftercare.

3. Post-Procedure

Following the administration of the DTaP-IPV/Hib vaccine, patients may experience mild side effects such as soreness at the injection site, low-grade fever, or irritability. These reactions are typically short-lived and resolve without intervention. It is important for the healthcare provider to inform the patient or caregiver about these potential side effects and advise them on when to seek further medical attention. Additionally, documentation of the vaccine administration, including the date, lot number, and site of injection, should be recorded in the patient's medical record to ensure proper tracking of immunizations and compliance with public health guidelines.